in this issue
Chemical Week Magazine :: Other
Metabolix Targets Integrated Chemical Production
6:56 AM MDT | April 20, 2012 | Rebecca Coons
Less than three months after Archer Daniels Midland’s (ADM) exit from bioplastics joint venture Telles left an uncertain future for partner Metabolix (Cambridge, MA) and its biobased polyhydroxyalkanoate (PHA) technology, Metabolix CEO Rick Eno tells CW the company will soon relaunch with a more profitable business model, smaller-scale manufacturing facility, and an expanded product slate integrating biopolymers and biobased chemicals. Renewable Revamp: PHA outlook remains bright. ADM’s exit left Metabolix in a bind. The agribusiness giant retained...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee